My Account
My Account

FDA

Latest Stories
FDA
Veterinary Regulations

FDA Reorganizes Animal Drug Evaluation Structure to Better Align Innovative Products, Generic Drugs
The realignment comes at a critical time in the animal drug review program, the agency reports.
October 07, 2024 11:07 AM
 · 
FDA
Livestock
Veterinary Education
Registration Now Open for FDA 2024 One Health Virtual Symposium
The “Paws, Claws, Hooves, Fins, and Feet—Advancements through a One Health Approach” virtual One Health symposium is set for Nov. 19, 2024. RACE credits are available.
October 07, 2024 09:24 AM
 · 
FDA
FDA
Veterinary Education
FDA Addresses Veterinarian-Client-Patient Relationships, Prescribing/Dispensing Animal Drugs and Telemedicine
The agency has developed an online Q&A to answer questions about veterinarians’ federal requirements with regard to these topic areas.
September 06, 2024 09:47 AM
 · 
FDA
Data from NARMS are used by FDA in the regulatory review of new animal antimicrobial drugs, and to develop policies on judicious antimicrobial use in animals.
Education
FDA Releases Summary of 2019 NARMS Report
Data from NARMS are used by FDA in the regulatory review of new animal antimicrobial drugs, and to develop policies on judicious antimicrobial use in animals.
April 20, 2022 02:21 PM
 · 
FDA
Researchers at work.
Veterinary Research
FDA Issues Draft Guidance on Donor Eligibility and Manufacturing of Cellular Therapies for Animals
“ACTPs have the potential to make significant changes in how we treat diseases and may provide novel therapies for unmet therapeutic needs of animals,” reports Dr. Janet Woodcock, Acting Commissioner of the FDA.
September 27, 2021 02:48 PM
 · 
FDA
The U.S. Food and Drug Administration continues to work with stakeholders to address antiparasitic resistance in livestock (cattle, sheep, goats, swine, and poultry) and horses.
Industry
FDA Continues to Address Antiparasitic Resistance in Livestock
Parasites are becoming increasingly resistant to drugs that were generally effective against them in the past.
November 19, 2020 11:54 PM
 · 
FDA
The U.S. Food and Drug Administration this week released draft Guidance for Industry, entitled “Eligibility Criteria for Expanded Conditional Approval of New Animal Drugs.”
Veterinary Regulations
FDA Issues Draft GFI on Conditional Drug Approvals
Expanded conditional approval has the potential to incentivize drug development and provide veterinarians with legally marketed new animal drugs.
November 19, 2020 11:51 PM
 · 
FDA
Changes to the use conditions of these products will be based on science and available evidence, and the FDA believes this RFA will help generate such information.
Veterinary Regulations
FDA Offers Funds for Duration of Use Studies
Research needed to help define duration of use for certain medically important antimicrobial drugs for food animals.
November 10, 2020 08:11 PM
 · 
FDA
The new draft guidance is titled “Compounding Animal Drugs from Bulk Drug Substances.”
Veterinary Regulations
FDA Hosts Webinar on Animal Drug Compounding
On November 21, 2019, at 1:00-2:30 p.m. EST, the FDA’s Center for Veterinary Medicine will hold a public webinar about the agency’s newly-released draft Guidance for Industry #256.
November 10, 2020 08:11 PM
 · 
FDA
The site includes graphic illustrations showing trends associated with the five-year plan.
Veterinary Regulations
FDA Announces Veterinary AMR Performance Measures on FDA-TRACK
Performance measures track the progress of the Center of Veterinary Medicine’s (CVM) Five-Year Plan for Supporting Antimicrobial Stewardship in Veterinary Settings.
November 10, 2020 08:11 PM
 · 
FDA
Load More